Sano, The Population Council Inc. deal

SANO received exclusive North American rights to use the Council’s Nestorone synthetic progestin in transdermal patches for female hormone replacement therapy and contraception. The license includes an option for SANO to receive exclusive worldwide rights to transdermal application of the MENT synthetic androgen to treat hypogonadism and in male contraception and wasting. ...